Similar articles for PMID: 29748614

Year	Number of Results
2001	1
2006	1
2008	1
2009	1
2010	1
2011	1
2012	2
2013	4
2014	10
2015	8
2016	15
2017	18
2018	19
2019	18
2020	10
2021	8
2022	2
2023	0

1

Nanovesicle-mediated delivery of anticancer agents effectively induced cell death and regressed intrahepatic tumors in athymic mice.

George J, Yan IK, Patel T. George J, et al. Lab Invest. 2018 Jul;98(7):895-910. doi: 10.1038/s41374-018-0053-4. Epub 2018 May 10. Lab Invest. 2018. PMID: 29748614 Free article.

2

Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance.

Wang C, Wei X, Shao G. Wang C, et al. Med Sci Monit. 2021 Feb 1;27:e927727. doi: 10.12659/MSM.927727. Med Sci Monit. 2021. PMID: 33524008 Free PMC article.

3

Effect of PEG-PDLLA polymeric nanovesicles loaded with doxorubicin and hematoporphyrin monomethyl ether on human hepatocellular carcinoma HepG2 cells in vitro.

Xiang GH, Hong GB, Wang Y, Cheng D, Zhou JX, Shuai XT. Xiang GH, et al. Int J Nanomedicine. 2013;8:4613-22. doi: 10.2147/IJN.S54142. Epub 2013 Dec 2. Int J Nanomedicine. 2013. PMID: 24324333 Free PMC article.

4

Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer.

Chang JE, Yoon IS, Sun PL, Yi E, Jheon S, Shim CK. Chang JE, et al. J Photochem Photobiol B. 2014 Nov;140:49-56. doi: 10.1016/j.jphotobiol.2014.07.005. Epub 2014 Jul 24. J Photochem Photobiol B. 2014. PMID: 25090224

5

Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma.

Xia Y, Zhong J, Zhao M, Tang Y, Han N, Hua L, Xu T, Wang C, Zhu B. Xia Y, et al. Drug Deliv. 2019 Dec;26(1):1-11. doi: 10.1080/10717544.2018.1556359. Drug Deliv. 2019. PMID: 31928356 Free PMC article.

6

Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.

Zhang F, Jia Y, Zheng X, Shao D, Zhao Y, Wang Z, Dawulieti J, Liu W, Sun M, Sun W, Pan Y, Cui L, Wang Y, He K, Zhang M, Li J, Dong WF, Chen L. Zhang F, et al. Acta Biomater. 2019 Dec;100:352-364. doi: 10.1016/j.actbio.2019.09.034. Epub 2019 Sep 26. Acta Biomater. 2019. PMID: 31563690

7

Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.

Gao B, Luo J, Liu Y, Su S, Fu S, Yang X, Li B. Gao B, et al. Int J Nanomedicine. 2021 Jun 15;16:4073-4085. doi: 10.2147/IJN.S308057. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34163160 Free PMC article.

8

Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.

Ding Y, Han J, Tian B, Han J, Zhang J, Zheng H, Han Y, Pei M. Ding Y, et al. Int J Pharm. 2014 Dec 30;477(1-2):187-96. doi: 10.1016/j.ijpharm.2014.10.024. Epub 2014 Oct 16. Int J Pharm. 2014. PMID: 25455771

9

Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.

Xu Y, Lu Y, Wang L, Lu W, Huang J, Muir B, Yu J. Xu Y, et al. Colloids Surf B Biointerfaces. 2016 May 1;141:318-326. doi: 10.1016/j.colsurfb.2016.01.044. Epub 2016 Jan 28. Colloids Surf B Biointerfaces. 2016. PMID: 26874117

10

TPGS-Galactose-Modified Polydopamine Co-delivery Nanoparticles of Nitric Oxide Donor and Doxorubicin for Targeted Chemo-Photothermal Therapy against Drug-Resistant Hepatocellular Carcinoma.

Du Z, Mao Y, Zhang P, Hu J, Fu J, You Q, Yin J. Du Z, et al. ACS Appl Mater Interfaces. 2021 Aug 4;13(30):35518-35532. doi: 10.1021/acsami.1c09610. Epub 2021 Jul 21. ACS Appl Mater Interfaces. 2021. PMID: 34286569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

103 results

Results by year